quintilesIMS Archives -

Learn innovative solutions to address these challenges

Top 5 challenges of immuno-oncology clinical trials

https://pharmaphorum.com/partner-content-oncology/top-5-challenges-of-immunooncology-clinical-trials/

Cancer/ Clinical/ Oncology/ Partner Content/ Press releases/ Quintiles-oncol-PC

Oncology – the current landscape and what it means for the future

Adam Jeffery cancer, forecast, global, insight, institute, IQVIA, Oncology, quintilesIMS, Spotlight 0 Comment

The WHO reports that in 2015, cancer was the second highest cause of death globally – responsible for

Oncology – the current landscape and what it means for the future

https://pharmaphorum.com/partner-content-oncology/oncology-current-landscape-means-future/

Oncology/ Partner content/ Partner Content/ Press releases/ Quintiles - ContentIO

How RACE legislation is changing the face of pediatric oncology in the US

Adam Jeffery cancer, clinical trials, IQVIA, legislation, Oncology, paediatric, quintilesIMS, US 0 Comment

On August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity

How RACE legislation is changing the face of pediatric oncology in the US

https://pharmaphorum.com/partner-content-oncology/race-legislation-changing-face-pediatric-oncology-us/

Debates/ Debates & Insight/ Digital and Social Media/ Sales and Marketing/ Webinars/ Webinars in home page/ Webinars On demand

11/23/2017

The evolution of pharma social media intelligence

mike.hammerton@pharmaphorum.com Digital / Social media, IQVIA, marketing, quintilesIMS 0 Comment

Is your company a fully mature user of intelligence from social media, or is it still not tapping

The evolution of pharma social media intelligence

https://pharmaphorum.com/debates-insight-sales-marketing/evolution-pharma-social-media-intelligence/

Cancer/ Quintiles - Oncol articles/ Views and analysis

Biosimilars in oncology: a €2billion opportunity for European healthcare

Marco Ricci biosimilars, cancer, Funding, healthcare, IQVIA, Oncology, quintilesIMS 0 Comment

IQVIA’s Murray Aitken examines the potential for savings from a new wave of oncology biosimilars – but says

Biosimilars in oncology: a €2billion opportunity for European healthcare

https://pharmaphorum.com/views-and-analysis/biosimilars-oncology-european-healthcare/

Clinical/ Healthcare/ Sales and Marketing/ Views and analysis

The Patient Summit Europe – Day 2 coverage

Adam Jeffery adherence, centric, eyeforpharma, patients, pharma, quintilesIMS, trials 0 Comment

Full coverage from day 2 (Oct 19th 2017) of the European Patient Summit 2017 below. Day one coverage

The Patient Summit Europe – Day 2 coverage

https://pharmaphorum.com/views-and-analysis/patient-summit-europe-day-2-coverage/

EyeForPharma 2018 Banner 840x470 DAY 1 1

Clinical/ Healthcare/ Sales and Marketing/ Views and analysis

The Patient Summit Europe – Day 1 coverage

Adam Jeffery adherence, centric, eyeforpharma, patients, pharma, quintilesIMS, trials 0 Comment

Full coverage from day 1 (Oct 19th 2017) of the European Patient Summit 2017 below. Day two coverage

The Patient Summit Europe – Day 1 coverage

https://pharmaphorum.com/views-and-analysis/patient-summit-europe-day-1-coverage/

Clinical/ Healthcare/ Partner content/ Partner Content/ Patient Summit PC/ Patients/ Press releases

Placing the patient at the centre

Adam Jeffery clinical trial, data, endpoints, Jean Paty, patient-centric, quintilesIMS 0 Comment

There’s much talk about patient-centric trials – collecting feedback and insight from patients and incorporating it into study

Placing the patient at the centre

https://pharmaphorum.com/partner-content-patients/placing-patient-centre/

Healthcare/ Partner content/ Partner Content/ Patient Summit PC/ Patients/ Press releases

How to fix your adherence problem

Adam Jeffery adherence, data, patients, payers, quintilesIMS, WHO 0 Comment

Typical patient support programs fail to improve adherence – and it’s costing the pharma industry billions. Here’s how

How to fix your adherence problem

https://pharmaphorum.com/partner-content-patients/fix-adherence-problem/

Trending

quintilesIMS

Login